These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8915161)

  • 1. Beneficial effect of granulocyte-colony stimulating factor in scleromyxoedema associated with severe idiopathic neutropenia.
    Cohen AM; Hodak E; David M; Mittelman M; Gal R; Stern R
    Br J Dermatol; 1996 Oct; 135(4):626-9. PubMed ID: 8915161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Granulocyte colony-stimulating factor corrects the neutropenia associated with glycogen storage disease type Ib.
    Wang WC; Crist WM; Ihle JN; Arnold BA; Keating JP
    Leukemia; 1991 Apr; 5(4):347-9. PubMed ID: 1709246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of granulocyte colony-stimulating factor in the treatment of fever and neutropenia in a heart transplant patient.
    Gordon MS; O'Donnell JA; Mohler ER; Cooper MA
    J Heart Lung Transplant; 1993; 12(4):706-7. PubMed ID: 7690254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of granulocyte colony-stimulating factor on quality of life in patients with severe chronic neutropenia.
    Fazio MT; Glaspy JA
    Oncol Nurs Forum; 1991; 18(8):1411-4. PubMed ID: 1722310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant human granulocyte colony stimulating factor in patients with systemic lupus erythematosus associated neutropenia and refractory infections.
    Euler HH; Harten P; Zeuner RA; Schwab UM
    J Rheumatol; 1997 Nov; 24(11):2153-7. PubMed ID: 9375876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Granulocyte colony-stimulating factor treatment for cyclophosphamide-induced severe neutropenia in Wegener's granulomatosis.
    Hellmich B; Schnabel A; Gross WL
    Arthritis Rheum; 1999 Aug; 42(8):1752-6. PubMed ID: 10446877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Granulocyte colony-stimulating factors in the management of chemotherapy-induced neutropenia: evidence based review.
    Bhana N
    Curr Opin Oncol; 2007 Jul; 19(4):328-35. PubMed ID: 17545795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of two different rG-CSF preparations in the treatment of patients with severe congenital neutropenia.
    Carlsson G; Ahlin A; Dahllöf G; Elinder G; Henter JI; Palmblad J
    Br J Haematol; 2004 Jul; 126(1):127-32. PubMed ID: 15198743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The use of a colony-stimulating factor (G-CSF) in iatrogenic neutropenias].
    Martínez Ruiz M; Llobell Segui G; Peralba Vaño JI; Toral Revuelta JR; Mellado del Rey F; González de Aledo GB
    An Med Interna; 1992 Dec; 9(12):624. PubMed ID: 1283082
    [No Abstract]   [Full Text] [Related]  

  • 10. Severe chronic neutropenia: treatment and follow-up of patients in the Severe Chronic Neutropenia International Registry.
    Dale DC; Cottle TE; Fier CJ; Bolyard AA; Bonilla MA; Boxer LA; Cham B; Freedman MH; Kannourakis G; Kinsey SE; Davis R; Scarlata D; Schwinzer B; Zeidler C; Welte K
    Am J Hematol; 2003 Feb; 72(2):82-93. PubMed ID: 12555210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of granulocyte colony-stimulating factor in neutropenic children.
    Justo LF; Cedola A
    Pediatr Infect Dis J; 1994 Nov; 13(11):1024-5. PubMed ID: 7531319
    [No Abstract]   [Full Text] [Related]  

  • 12. Reversal of autoimmune phenomena in autoimmune neutropenia after treatment with rhG-CSF: two additional cases.
    Carulli G; Sbrana S; Azzarà A; Minnucci S; Angiolini C; Ambrogi F
    Br J Haematol; 1997 Mar; 96(4):877-8. PubMed ID: 9074439
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of molgramostim, filgrastim and lenograstim in the treatment of myelokathexis.
    Cernelc P; Andoljsek D; Mlakar U; Pretnar J; Modic M; Zupan IP; Zver S
    Pflugers Arch; 2000; 440(5 Suppl):R81-2. PubMed ID: 11005621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy.
    Wong SF; Chan HO
    Pharmacotherapy; 2005 Mar; 25(3):372-8. PubMed ID: 15843284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Failure of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in a patient with Kostmann syndrome.
    Hazar V; Ongun H; Yeşilipek MA; Yeğin O
    Turk J Pediatr; 1999; 41(1):117-20. PubMed ID: 10770686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chronic neutropenia].
    Palmblad J; Elinder G
    Nord Med; 1996 Nov; 111(9):304-7. PubMed ID: 8966113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tongue ulcer in azidothymidine-induced neutropenia. Rapid increase in neutrophils and healing of the ulcer by substitution of recombinant human granulocyte colony stimulating factor (rhG-CSF)].
    Schwander S; Kern P
    Med Klin (Munich); 1993 Feb; 88(2):60-2. PubMed ID: 7680750
    [No Abstract]   [Full Text] [Related]  

  • 18. [Chronic benign neutropenia(CBN)].
    Tanaka M; Tsukimoto I
    Ryoikibetsu Shokogun Shirizu; 2000; (32):157-9. PubMed ID: 11212674
    [No Abstract]   [Full Text] [Related]  

  • 19. Umbilical cord blood stem cell transplantation from unrelated HLA-matched donor in an infant with severe congenital neutropenia.
    Mino E; Kobayashi R; Yoshida M; Suzuki Y; Yamada M; Kobayashi K
    Bone Marrow Transplant; 2004 May; 33(9):969-71. PubMed ID: 15004540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical use of granulocyte colony stimulating-factors (GM-CSF and G-CSF].
    Borota R; Borota J; Belić A; Gebauer E; Stefanović N
    Med Pregl; 1997; 50(3-4):87-93. PubMed ID: 9229690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.